American Society of Gene and Cell Therapy

0:03:32

ASGCT: The Home of Cell and Gene Therapy

0:03:07

What's the Difference Between Gene Therapy, Cell Therapy, and Gene Editing?

0:04:05

Gene Therapy Basics (2022 Update)

0:56:13

Around the World: Australasian Gene and Cell Therapy Society (AGCTS)

0:22:31

Gene and Cell Therapy for Immunodeficiency Syndromes

0:17:14

Real-World Challenge: Establishing the Value of Gene Therapy for Patients

0:27:43

Overview of Standards Setting for Cell/Gene Therapies-- Case Studies

0:18:10

Gene Therapy for Hemophilia

0:57:07

The Makings of a Living Drug

0:20:18

Gene Therapy for Vision Disorders

0:24:43

Gene Editing of Stem Cells for Universal Cell Therapy - Joanna Brewer

0:23:15

The Challenge to Develop and Commercialize Gene-Based Therapies for Rare Diseases

0:06:21

Dr. Paloma Giangrande 2013 ASGCT ONI Award Recipient

0:03:38

ASGCT/ESGCT Joint Clinical Trials Training Course Preview: Dr. Barrie J. Carter, PhD

0:26:56

Preparing for Launch and Adjusting the Constant of Evolution in Gene Therapy

0:34:43

Immunogenicity of AAV Vectors and Transgenes - Roland Herzog

0:32:49

In Utero Gene Therapy

0:38:35

Ethics: from Clinical Trials to Products - Jonathan Kimmelman

0:37:55

Dissecting and Overcoming Innate Immune Barriers for Efficient Stem Cell Gene Engineering

0:03:30

Gene Therapy Basics

0:37:14

2022 WMIF | Gene and Cell Therapy | The World Speaks

4:24:07

Forum on Gene Therapy for Underserved Populations

0:21:03

Gene Therapy for X-Linked Chronic Granulomatous Disease - Donald Kohn

0:55:21

Recent CMC Guidance for Cellular and Gene Therapies: BIO-ASGCT CGT Science Series